Polo‐like kinase (Plk) 1: a novel target for the treatment of prostate cancer
Open Access
- 3 November 2003
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 18 (1) , 5-7
- https://doi.org/10.1096/fj.03-0848hyp
Abstract
Second only to skin cancer, cancer of the prostate gland (CaP) is the most commonly occurring cancer in American men. Existing treatment approaches and surgical intervention have been unable to effec...Keywords
This publication has 12 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Effect of RNA Silencing of Polo-Like Kinase-1 (PLK1) on Apoptosis and Spindle Formation in Human Cancer CellsJNCI Journal of the National Cancer Institute, 2002
- Expression of polo‐like kinase (PLK1) in thin melanomas: a novel marker of metastatic diseaseJournal of Cutaneous Pathology, 2002
- Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNAProceedings of the National Academy of Sciences, 2002
- Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cellsOncogene, 2002
- Centrosomes as command centres for cellular controlNature Cell Biology, 2001
- Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophaseNature, 2001
- Managing the centrosome numbers game: from chaos to stability in cancer cell divisionTrends in Cell Biology, 2001
- Polo-like kinase-1 is a target of the DNA damage checkpointNature Cell Biology, 2000
- Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.The Journal of cell biology, 1996